Full-Time

Business Platform Analyst

Philips

Philips

Healthcare technology for diagnosis, care, wellness

Compensation Overview

$70k - $110k/yr

+ Annual Incentive Bonus + Long-Term Incentives + Stock Purchase Plan

No H1B Sponsorship

Wayzata, MN, USA

Hybrid

Must reside within commuting distance to Plymouth, Minnesota.

Bachelor's

Category
DevOps & Infrastructure (1)
Required Skills
Power BI
SharePoint
Data Lake
Microsoft Azure
ETL
REST APIs
Excel/Numbers/Sheets
Requirements
  • You’ve acquired experience through internships, academic projects, or early-career roles in systems engineering or a related field. Prior professional experience is not required, but exposure to these areas is preferred.
  • No prior experience required with Bachelor's Degree OR minimum 4 years of experience with Vocational Education in areas such as Solution Design and Architecture, DevOps Practices, IT Platforms Performance Optimization or equivalent.
  • Your Bachelor's Degree/Vocational Education in Computer Science, Information Technology, Software Engineering or equivalent.
  • Your preferred skills include strong analytical, technical, and problem-solving skills with the ability to translate business requirements into scalable system and process solutions. Demonstrated experience supporting enterprise applications, databases, reporting platforms, and business systems is required.
  • A preferred candidate could have hands-on experience with technical tools such as Microsoft Power Platform (Power Apps, Power Automate, Power BI), Microsoft Dynamics 365, SQL Server, Azure Data Factory, Azure DevOps, SharePoint, Microsoft 365, Excel, and API integration tools.
  • Experience working with data lakes, ETL processes, relational databases, SaaS platforms, cloud technologies, and system integrations is highly desirable.
Responsibilities
  • Drive platform stability and operational excellence by troubleshooting system and process issues, resolving failures efficiently, and providing ongoing application support.
  • Ensure business continuity through proactive monitoring, maintenance, and timely issue resolution across the application lifecycle.
  • Analyze business needs and deliver technology solutions by evaluating existing processes, identifying improvement opportunities, and designing solutions that align with organizational objectives.
  • Apply established standards and best practices to improve platform efficiency, effectiveness, and scalability.
  • Partner with stakeholders and cross-functional teams to gather requirements, assess solution feasibility, and support successful project delivery.
  • Foster strong relationships through regular communication, collaboration, training, and change management activities that drive adoption and user success.
  • Lead quality assurance and solution validation efforts by developing test strategies, creating test cases, overseeing automation and regression testing, and ensuring thorough execution.
  • Support application deployments and post-go-live activities to maintain system reliability and performance.
  • Promote continuous improvement and compliance by staying current on emerging technologies, industry trends, and platform capabilities.
  • Maintain accurate documentation and exercise independent judgment within established processes to ensure quality, compliance, and operational effectiveness.
Desired Qualifications
  • Microsoft Power Platform (Power Apps, Power Automate, Power BI)
  • Microsoft Dynamics 365
  • SQL Server
  • Azure Data Factory
  • Azure DevOps
  • SharePoint
  • Microsoft 365
  • Excel
  • API integration tools
  • Data lakes
  • ETL processes
  • Relational databases
  • SaaS platforms
  • Cloud technologies
  • System integrations

Philips develops health technology across professional medical devices, connected care, and consumer health products. Its offerings include diagnostic imaging and image-guided therapy, patient monitoring and clinical informatics, and everyday wellness products like oral and personal care. The company increasingly delivers integrated solutions through a Healthcare-as-a-Service subscription model and long-term partnerships with hospitals and health systems. Its aim is to improve people’s health and well-being by making advanced health technology easier to access and integrate into care.

Company Size

N/A

Company Stage

IPO

Headquarters

Andover, Minnesota

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • May 18, 2026 Stockholm selected Philips for hospital-at-home coverage across up to 15,000 patients annually.
  • Q1 2026 sales grew 4%, and Philips reiterated 2026 guidance on May 13, 2026.
  • 2025 free cash flow reached EUR 512 million, supporting investment and shareholder returns.

What critics are saying

  • August 2026 MDL still holds 624 Philips CPAP cases, extending legal drag.
  • January 19, 2026 settlement covers economics only; DOJ consent-decree talks still threaten Respironics.
  • A Respironics compliance failure can block U.S. sleep-device sales and tarnish Philips brand.

What makes Philips unique

  • June 4, 2026 WellSpan alliance makes Philips preferred vendor across CT, MR, X-ray, ultrasound, image-guided therapy.
  • August 6, 2026 ecosystem partnerships connect Philips monitoring from hospital beds to homes.
  • Philips combines diagnosis, connected care, and personal health across 64,317 employees at Q1 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

PR Newswire
May 28th, 2026
Remote patient monitoring market to reach $117.9B by 2033 amid digital healthcare transformation

The global remote patient monitoring market is expected to grow from $67.3 billion in 2026 to $117.9 billion by 2033, registering a CAGR of 8.3%. Growth is driven by rising chronic disease prevalence, expanding telehealth services and increasing demand for home-based healthcare solutions. Devices and hardware account for nearly 38% of market share, led by connected blood pressure monitors, glucometers and wearable health trackers. North America holds approximately 41% of the global market, supported by strong digital healthcare infrastructure and favourable reimbursement policies. Asia Pacific is emerging as the fastest-growing region, driven by healthcare digitisation, telemedicine expansion and rising smartphone penetration. Leading players include Philips Healthcare, Medtronic, GE HealthCare and Abbott Laboratories, focusing on AI integration and cloud connectivity to enhance remote care delivery.

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

YourLawyer.com
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.